Herantis Pharma published the Annual report for 2022
Herantis Pharma Plc Company Release, March 28, 2023, at 8:00 a.m. EEST/7:00 a.m. CEST Herantis Pharma Plc (“Herantis”), a company developing disease-modifying therapies for Parkinson’s disease, has today published the annual report for 2022. The Annual Report contains financial statements and the report of the Board of Directors. The Annual Report is available in PDF format as appendix to this release and on Herantis Pharma’s website: https://herantis.com/investors/financial-reports/ For more information, please contact: Julie Silber/Gabriela Urquilla Tel: +46 (0)7 93 486 277/